Pharma Journalist -

The Sabin Vaccine Institute announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to…
Read More...

AstraZeneca’s Tezspire (tezepelumab) has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) for self-administration in…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered an option and research collaboration agreement with Monash University (Melbourne, Victoria, Australia) to discover and develop…
Read More...

Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, announced that the U.S. Food and…
Read More...

Daiichi Sankyo announced the submission of an application for marketing approval of DS-5670 to the regulatory authorities in Japan. DS-5670 is an mRNA vaccine, being developed against…
Read More...

Takeda announced that EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with locally advanced…
Read More...

On January 6, 2023, Health Canada approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast…
Read More...

Catalent, the global leader in enabling the development and supply of better treatments across multiple modalities, and Ethicann Pharmaceuticals Inc., a Canadian/U.S. specialty…
Read More...

Myrtelle Inc., a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, and rAAVen Therapeutics, (“rAAVen”) an AAV…
Read More...

Merck, known as MSD outside of the United States and Canada, announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of…
Read More...